Divi's Laboratories Limited (NSE:DIVISLAB)
India flag India · Delayed Price · Currency is INR
11,485
+118 (1.04%)
Nov 12, 2026, 3:29 PM IST

Divi's Laboratories Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
22,3601,2804,1503,6301,70012,148
Short-Term Investments
-31,05031,12033,35039,63015,269
Cash & Short-Term Investments
22,36032,33035,27036,98041,33027,417
Cash Growth
-31.43%-8.34%-4.62%-10.53%50.75%31.76%
Accounts Receivable
34,87031,09027,31021,56017,93024,239
Other Receivables
-3,4202,4602,0501,4101,045
Receivables
34,87034,51029,77023,61019,34025,283
Inventory
55,40039,54032,36031,84030,00028,286
Prepaid Expenses
-260370360260270.9
Other Current Assets
11,7604,3203,0403,9602,1902,258
Total Current Assets
124,390110,960100,81096,75093,12083,515
Property, Plant & Equipment
90,96086,35064,60055,13049,29047,875
Long-Term Investments
710690650820770720.1
Other Intangible Assets
1506040405074.9
Long-Term Deferred Tax Assets
130140110100140144.7
Other Long-Term Assets
3,3002,1303,1101,8601,0201,418
Total Assets
219,640200,330169,320154,700144,390133,747

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
17,59012,1109,1008,2407,6207,957
Accrued Expenses
6404,0303,6502,4402,5503,235
Short-Term Debt
--20---
Current Portion of Leases
2020-10108.2
Current Income Taxes Payable
810120-4302016.8
Current Unearned Revenue
-2,69041010107.6
Other Current Liabilities
8,0101,4601,3401,650800731.3
Total Current Liabilities
27,07020,43014,52012,78011,01011,956
Long-Term Leases
405020203028.7
Pension & Post-Retirement Benefits
2,330810----
Long-Term Deferred Tax Liabilities
4,6304,6905,0905,8205,3704,214
Other Long-Term Liabilities
5,6006,740-370310267.1
Total Liabilities
39,67032,72019,63018,99016,72016,465

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
530530530530530530.9
Additional Paid-In Capital
-800800800800798.8
Retained Earnings
-165,820148,050134,120126,090115,797
Comprehensive Income & Other
179,440460310260250155.1
Shareholders' Equity
179,970167,610149,690135,710127,670117,282
Total Liabilities & Equity
219,640200,330169,320154,700144,390133,747

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
607040304036.9
Net Cash (Debt)
22,30032,26035,23036,95041,29027,380
Net Cash Growth
-29.68%-8.43%-4.66%-10.51%50.80%31.89%
Net Cash Per Share
84.03121.52132.71139.19155.54103.14
Filing Date Shares Outstanding
265.24265.47265.47265.47265.47265.47
Total Common Shares Outstanding
265.24265.47265.47265.47265.47265.47
Working Capital
97,32090,53086,29083,97082,11071,560
Book Value Per Share
678.52631.37563.87511.21480.92441.79
Tangible Book Value
179,820167,550149,650135,670127,620117,207
Tangible Book Value Per Share
677.95631.15563.72511.06480.73441.51
Land
-3,0602,0201,9501,9401,727
Machinery
-66,31055,00048,63045,77039,860
Construction In Progress
-21,13010,2207,7802,1204,699